Structures by: Chen C. A.
Total: 7
Cpd1
C19H23ClFNO4S
Journal of medicinal chemistry (2018) 61, 11 4810-4831
a=22.010(5)Å b=9.223(2)Å c=9.454(2)Å
α=90.00° β=100.101(5)° γ=90.00°
C3H13B7N2O12
C3H13B7N2O12
Dalton transactions (Cambridge, England : 2003) (2020) 49, 12 3750-3757
a=8.7174(6)Å b=14.5181(11)Å c=10.5302(9)Å
α=90° β=101.859(7)° γ=90°
CH4Al2B15K3.52Na3.48O33
CH4Al2B15K3.52Na3.48O33
Dalton transactions (Cambridge, England : 2003) (2020) 49, 12 3750-3757
a=6.9842(3)Å b=10.2320(4)Å c=20.6780(10)Å
α=76.392(4)° β=86.700(4)° γ=82.594(3)°
Bis(8-methoxyquinoline-κ^2^<i>N</i>,<i>O</i>)bis(thiocyanato-κ<i>N</i>)copper(II)
C22H18CuN4O2S2
Acta Crystallographica Section C (2020) 76, 7
a=9.7940(3)Å b=9.7940(3)Å c=19.8673(8)Å
α=90.00° β=90.00° γ=120.00°
Di-μ-methanolato-κ^4^<i>O</i>:<i>O</i>-bis[(8-methoxyquinoline-κ^2^<i>N</i>,<i>O</i>)(thiocyanato-κ<i>N</i>)copper(II)]
C24H24Cu2N4O4S2
Acta Crystallographica Section C (2020) 76, 7
a=7.5050(11)Å b=7.9967(7)Å c=11.9102(19)Å
α=76.112(10)° β=71.827(14)° γ=82.057(9)°
Al-TADDOLate
C37H41AlO5
Acta Crystallographica Section E (2007) 63, 11 m2665-m2666
a=9.6123(8)Å b=15.7991(13)Å c=21.4207(18)Å
α=90.00° β=90.00° γ=90.00°
(<i>N</i>,<i>N</i>-dibenzylideneethane-1,2-diamine)dichloro(2,2-dimethyl-α, α,α',α'-tetraphenyl-1,3-dioxolane-4,5-methanolato)titanium(IV) or Ti-TADDOLate
C47H44Cl2N2O4Ti
Acta Crystallographica Section E (2007) 63, 11 m2842-m2843
a=9.9044(9)Å b=18.8261(17)Å c=23.238(2)Å
α=90.00° β=90.00° γ=90.00°